Zepbound and Trulicity are two U.S. Food and Drug Administration (FDA)-approved medications. When used alongside diet and ...

Novo Nordisk'sNVO oral Wegovy snagged 3,071 prescriptions in its first week on the market, an analyst said Friday. Novo Nordisk stock jumped on the news. In comparison, Eli Lilly'sLLY weight-loss shot ...

For years, GLP-1 drugs like Wegovy and Zepbound have transformed the discussion around obesity — but left millions locked out by high price tags, including Medicare recipients. That changes this week.

Sign up here to get The Boston Globe’s latest food stories delivered to your inbox once a week. In April, I went public with a secret: I’d begun taking the weight ...

Medicare will soon cover costs of weight-loss drugs. Here’s what you can expect to pay. - Popular Novo Nordisk and Eli Lilly ...

Contrave and Zepbound are two U.S. Food and Drug Administration (FDA)-approved medications for weight loss when combined with diet and exercise. But each medication works in different ways in the body ...

Zealthy announced today the launch of its enhanced virtual weight-loss care platform, designed to simplify access to provider-guided obesity treatment through integrated telehealth services, insurance ...

By Nancy Lapid July 14 (Reuters) - Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound ...